L. Beckmann

Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia

M. Hallek, R. Zahedi, S. Theurich, 2014, Leukemia.

Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapy

B. Gathof, M. Kochanek, J. Garcia Borrega, 2021, Clinical kidney journal.

BCL‐2‐family protein tBID can act as a BAX‐like effector of apoptosis

A. Villunger, A. García-Sáez, Xu Luo, 2021, The EMBO journal.

MARCKS affects cell motility and response to BTK inhibitors in CLL.

M. Hallek, S. Stilgenbauer, A. Wiestner, 2021, Blood.

Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy

G. Lenz, K. Rahbar, M. Dietlein, 2023, HemaSphere.

Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

R. Herwig, M. Peifer, M. Hallek, 2022, Blood.